Erica B. Kelly, M.D.
PRESENT POSITION AND ADDRESS: July 2002 to PRESENT
Clinical Associate Professor
Director of Cosmetic Dermatology
Course Director- Dermatology Ambulatory Care Selective
Department of Dermatology
University of Texas Medical Branch
301 University Blvd.
4.112 McCullough Building
Galveston, Texas 77555-0783
July 2001-June 2002 Co-Chief Resident, UTMB Dermatology
July 1999-June 2002 Dermatology Residency, UTMB Galveston
July 1998-June 1999 Internship, Internal Medicine, LSU, New Orleans
August 1994-1998 LSU University School of Medicine, New Orleans, Awarded M.D. Degree
August 1990-1994 Louisiana State University in Baton Rouge, B.S.
Graduated Magna Cum Laude (Microbiology)
OTHER MEDICAL EDUCATION:
Attended Training Course: National Hansen’s Disease Center, Baton Rouge, LA
Department of Health and Human Services
Attended Courses and have experience with Intense Pulsed Light Sources,
Q- Switched Nd:YAG, long-pulsed Alexandrite, 532 and 810 nm Diode lasers,
Botox, Restylane and Sculptra.
Selected to attend the 2005 AAD Leadership Conference
American Board of Dermatology, 2002
RESEARCH: Principal Investigator:
2003-2004 Dow Pharmaceutical Sciences
“A Multicenter, Open-Label Evaluation of the Adrenal Suppression Potential of Topically Applied
Desonide Gel 0.05% in Pediatric Subjects with Moderate to Severe Atopic Dermatitis”.
RESEARCH: As a Co-Investigator:
1997 – 1998 “A Double-Blind Study Comparing Two Doses of Valacyclovir HCI for the Treatment of Uncomplicated
Herpes Zoster in Immunocompromised Patients 18 Years of Age and Older” IRB #97-120
1998-2000 Fujisawa Healthcare, Inc Co-Investigator- “An Open Label, Long Term,
Follow-Up Study to Evaluate the Safety of Topically Applied Tacrolimus
Ointment for the Treatment of Atopic Dermatitis”. Protocol #97-0-038, IRB #98-459
1999 - 2000 Schering-Plough Research Institute
“Efficacy and Safety of SCH 34117 in the Treatment of Chronic Idiopathic Urticaria (CIU)” IRB #99-383.
1999 - 2000 Schering-Plough Research
“Efficacy and Safety of SCH 34117 in the Treatment of Atopic Dermatitis”
Protocol #P00224-09, IRB #99-254
1999-2001 Fujisawa Healthcare, Inc.
Co-Investigator, An Open Label Study to Evaluate the Safety of Topically Applied Tacrolimus Ointment
for the Treatment of Atopic Dermatitis, Protocol 99-0-054 IRB #99-129
1999-2000 Glaxo Wellcome, Inc.
Co-Investigator, A Randomized Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate Efficacy,
Quality of Life, and Safety Outcomes Associated with the Use of Topical Fluticasone Propionate Cream,
0.05% in Reducing Risk of Relapse in Adult and Pediatric Subjects with Stabilized Atopic Dermatitis,
Protocol #FPC40002 IRB #98-459.
2000 - 2001 Schering-Plough Research Institute
“A Phase IV Multi-Center, Open-Label Safety Study in Pediatric Patients With Atopic Dermatitis Treated
with Diprosone Ointment 0.5% Twice Daily.”
Protocol P01261 IRB #99-457
2000-2001 Schering-Plough Research Institute
“A Clinical Study to Evaluate the Safety and Efficacy of Mentax Cream (butenafine hydrochloride 1%) vs.
Vehicle Cream in the Treatment of Plantar Tinea Pedis (Moccasin Type)”
Protocol # CL2000-02 IRB #00-397.
2000 “A Study to Evaluate the Cell-Meditated Immune Responses of Herpes Zoster Patients Compared
to Healthy Subjects Over a Six-Month Period”
2001-2002 Fujisawa Healthcare, Inc.
“A Randomized, Double-Blind Study of Protopicâ 0.03% (Tacrolimus Ointment) vs. Vehicle Ointment in Pediatric
Patients with Mild to Moderate Atopic Dermatitis”.
Protocol 20-01-001 IRB #01-215 (Phase IV)
2001-2002 Novartis (PPD, Inc.)
“A 6 month, randomized, multicenter, parallel-group, double-blind, vehicle-controlled study to evaluate the efficacy
and safety of ASM 981 (pimecrolimus) cream 1% BID vs. standard of care management of mild to severe
atopic dermatitis in children 3 months to 11 years”.
Protocol CASM 981 US04 IRB #01-281
2002-2003 Atrix Laboratories (SFBC)
“A 12-Week, Multicenter, Double-Blind, Randomized, Parallel Design Study of 5%Dapsone Topical Gel
and Vehicle Control in Patients with Acne Vulgaris”.
Protocol DAP0204 IRB #02-423
2003 Fujisawa Healthcare, Inc.
“A Randomized, Investigator Blinded, Study of Protopic (Tacrolimus®) Ointment vs. Elidel (Pimecrolimus®) Cream
in Pediatric Patients with Mild Atopic Dermatitis.”
Protocol 20-02-006 IRB #03-191
2003 Fujisawa Healthcare, Inc (Quintiles)
“A Phase 3, Randomized, Double-Blind Study Comparing Twice Daily FK506 Cream 0.03%
Versus Cream Vehicle in the Treatment of Atopic Dermatitis in Pediatric Patients.
Protocol 03-0-183 IRB# 03-361.
2004 3M Pharmaceuticals
“Phase III Vehicle-controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod Cream,
5% for the Treatment of Molluscum Contagiosum in Pediatric Subjects”.
Protocol 1494-IMIQ IRB #04-001
2004 Dow Pharmaceutical Sciences (SFBC)
“A Randomized, Evaluator-Blind, 3-Arm, Multi-Center Study to Evaluate the Safety and Efficacy of Topically
Applied Desonide Gel 0.05% vs. Desonide Gel Vehicle and DesOwen Lotion for the Treatment of Pediatric
Subjects with Mild to Moderate Atopic Dermatitis.
Protocol # 7001-G3HP-04-03 IRB #04-070
2004 Ferndale Laboratories
“An Open Label Adrenal Suppression Study of Hydrocortisone Butyrate Lotion 0.1 % Used 3x Daily
in Pediatric Subjects Aged 3 Months to Less than 18 Years With Moderate to Severe Atopic Dermatitis”.
Protocol Number: 04-101 IRB # 04-268
2006-2008 “A Multi-center, Double-Blind, Randomized Start, Placebo-Controlled, Parallel-Group
Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson’s Disease Subjects.”
2008-2010 “A 24-month double-blind, randomized, Multicenter, placebo controlled, parallel-group study
comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily
versus placebo in patients with relapsing-remitting multiple sclerosis”.
NIH-SBIR-Subcontract; $169,000-Tissue clearing for cosmetic laser surgery. 2005-2006 – Co-Principal Investigator.
ADDITIONAL INFORMATION- COMMITTEES AND COMMUNITY SERVICE:
2008-present UTMB Ambulatory Community Selective Course Committee
2006-present American Society of Dermatologic Surgery External Communications Committee
2006 Bradley MDV Skin Cancer Screening, Shell Open Golf Tournament, Houston
2006- present American Cancer Society Relay for Life Fundraiser
2006- present UTMB Community Physician Partnerships Committee
2004- present UTMB Laser Safety Committee
2004 American Medical Women’s Association, female physician mentor
2001-2002 UTMB Graduate Medical Education Committee
1999-present Melanoma Skin Cancer Screening Program
1998 Member, Graduation Committee, LSUMC
1997-1998 Student Member, Alumni Board of Directors, LSUMC
1997-1998 Head of Investigation, Professional Conduct Committee,
1997-1998 President, Student Government Association, LSUMC
1997-1998 Co-Coordinator, LSUMS Family Day
1997-1998 Co-Author and Curriculum Sub-Committee Member for Peer Education Elective
1997-1998 Member, Student Accreditation Committee
1997 Participant, Christmas in October Community
Student Liaison, Health and Welfare Legislative Board
Participant, Habitat for Humanity
1996-1998 LSUMC Yearbook Representative
1996-1997 Secretary, Student Government Association, LSUMC
Speaker, New Orleans Outreach Program
1996 Editor, Tiger Bell Student Directory
1995-1997 Peer Support Group Leader for Freshmen
1995-1996 Speaker, Docs in Schools
1995 Participant, AHEC Primary Care Elective
2002-present Clinical Assistant Professor
2002-present 4th Year Medical Student Weekly Lecture
2003-present 2nd Year Medical Student Bi-annual Lecture
2001-present Noon Conference Internal Medicine Lectures
Mentor Medical Student Honors Program
2005-2006 Emily Fridlington
2007-2008 Mara Dacso
1994-1996 Tutor, Anatomy and Histology, LSUMC
DEPARTMENT OF DERMATOLOGY-UTMB:
Weekly Textbook Conference
Weekly Journal Club
Weekly Diagnostic Conference
Weekly Staff Clinic Attending
Private Clinic Resident Supervision- 3 times weekly
Annual Lectures: Dermal Fillers
IPL, Nd:YAG, and Diode Lasers
Arthropods of Medical Importance
Dermatology Jeopardy Week
Dermatology Cosmetic Clinic- Director
Common Dermatologic Diseases, Papulosquamous Diseases, Drug Eruptions, Skin Diseases Due to Microbial Agents, Reactive Erythemas, Benign Tumors of the Skin, Dermatology on the Ward, Skin Signs of Systemic Disease and Skin Signs of Internal Malignancy, Internal Medicine Noon Conferences and Grand Rounds throughout the year.
Botox: A New Wrinkle in the Fight Against Aging and Photoaging and Sun Protection, Women’s Group, Galveston Country Club.
Caring for our skin, UTMB Senior Night Out Program
Skin and Aging, UTMB Faculty Women’s Club
2007 Community panel discussion at Rosenberg library on “The Ties that Bind-doctors relationships with pharmaceutical companies”.
MEDICAL STUDENT TEACHING:
Director, Dermatology Ambulatory Community Selective, 4th year students
Monthly 4th year medical student lectures
Bi-annually 2nd year medical student lectures
Dermatology Interest Group lectures several times per year
CATCHUM online module on melanoma and another on non-melanoma skin cancer- this is an NIH funded cancer project to educate medical students around the country
DERMATOLGIC CONFERENCE PRESENTATIONS:
What’s New In Fillers? Texas Dermatological Society Annual Fall Meeting, November 2007.
What’s New In the Literature. Texas Dermatological Society Annual Spring Meeting, May 2005.
Extensive Necrobiosis Lipoidica Diabeticorum, Aneurysmal Dermatofibroma, Multiple Trichoepitheliomas in the Lines of Blaschko.
Houston Dermatological Society Clarence Livingood Lecture, March 2002.
Congential Unilateral Multiple Trichopitheliomas, Griscelli Syndrome. Society for Pediatric Dermatology’s Annual Meeting, June 2001.
Drug-Induced Linear IgA Bullous Dermatosis Mimicking Stevens-Johnson Syndrome.
American Academy of Dermatology’s 59th Annual Meeting, March 2001.
Secondary Syphilis, Extensive Lichen Sclerosis et Atrophicus. Houston Dermatological Society’s Clarence Livingood Lecture, March 2001.
Onset of Pityriasis Rubra Pilaris after Oral Terbinafine, Extensive Pyoderma Gangrenosum and Porphyria Cutanea Tarda.
Houston Dermatological Society’s Clarence Livingood Lecture, April 2000.
Connective Tissue Nevus, Neurofibromatosis Type I. Houston Dermatological Society’s John Knox Lecture, October 1999.
OTHER CONFERENCE PRESENTATIONS:
Infectious Skin Diseases in Athletes. 23rd Annual Conference on Innovations in Sports Medicine, July 2005.
Acne and Other Common Dermatologic Diseases. 40th Annual Family Medicine Review, Moody Gardens Convention Center, April 2006.
Dermatologic Manifestations of HIV. HIV Mini-Fellowship for UTMB’s Correctional Managed Care, November 2007.
Expert Roundtable Discussion participant for Reliant- formulated a clinical consensus on the use of the Fraxel SR750
MEMBERSHIPS IN PROFESSIONAL ORGANIZATIONS:
American Academy of Dermatology
American Society of Dermatologic Surgery
Galveston Medical Society
Houston Dermatological Society
Texas Dermatological Society
Life Member, LSU School of Medicine Alumni Association
American Medical Association
UTMB Graduate Medical Education Committee
Louisiana State University:
Golden Key Honor Society
Alpha Epsilon Delta Pre-med Honor Society
Beta Beta Beta Biological Honor Society
Mu Sigma Rho Honor Society
LSU Honor Scholarship
Phi Eta Sigma Honor Society
Alpha Omega Alpha, Beta Chapter
Aesculapian Society Intern of the Year Award
Dean’s Award, LSU Commencement Ceremony
Norma C. Ragland Award, Commencement Ceremony
Medical Student Award in Recognition of Excellent Dermatology Teaching, 2006
Medical Student Award in Recognition of Excellent Dermatology Teaching, 2007
Practical Reviews in Dermatology, John Hopkins University, Oakstone Publishing
Aerobics, Spinning, Weight training, Travel, Hiking, Digital Photography, Theater/Musicals
Erica B. Kelly, M.D.